Court documents confirm the settlement of hundreds of Paxil birth defect cases pending in the mass tort program in Philadelphia.
New York, NY (1888PressRelease) June 30, 2010 - An order signed on June 15, 2010 by Justice Sandra Moss, has paved the way for the settlement of of hundreds of Paxil birth defect cases pending against GlaxoSmithKline, GSK. No Paxil birth defect cases have been tried since the October 13, 2009, verdict where a jury awarded $2.5M to the family of Lyam Kilker, a child born with a congenital heart defect caused by Paxil use during pregnancy.
Approximately 600 cases have been filed against GSK, most in the Mass Tort Program in the Court of Common Pleas in Philadelphia. It has been reported by the Legal Intelligencer that Judge Moss, the coordinating judge of Philadelphia's mass tort program, the Complex Litigation Center, said the philosophy of GSK "is to try and settle what they can and to settle in groups."
While hundreds of cases may have been settled, many more may be filed. Parents who took Paxil during pregnancy and gave birth to a child with a congenital heart defect should act quickly to determine whether they my file a claim on behalf of their child.
Parents may visit www.DrugSettlement.com for more information.
If you or someone you know had a child who was born with a congenital heart defect or other birth defect, and the child was exposed to Paxil (paroxetine) during pregnancy, they may be entitled to significant compensation. For more information go to www.DrugSettlement.com.
Court documents confirm the settlement of hundreds of Paxil birth defect cases pending in the mass tort program in Philadelphia. 
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam